DK0999828T3 - Fremgangsmåde til fremstilling af præparater med aktivt middel til kontrolleret frigivelse fra en matrix - Google Patents

Fremgangsmåde til fremstilling af præparater med aktivt middel til kontrolleret frigivelse fra en matrix

Info

Publication number
DK0999828T3
DK0999828T3 DK98943632T DK98943632T DK0999828T3 DK 0999828 T3 DK0999828 T3 DK 0999828T3 DK 98943632 T DK98943632 T DK 98943632T DK 98943632 T DK98943632 T DK 98943632T DK 0999828 T3 DK0999828 T3 DK 0999828T3
Authority
DK
Denmark
Prior art keywords
controlled release
matrix
preparation
active agent
release preparations
Prior art date
Application number
DK98943632T
Other languages
English (en)
Inventor
Klaus Liebold
Joachim Wolf
Heiko Schumacher
Torsten Hoffmann
Original Assignee
Awd Pharma Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Awd Pharma Gmbh & Co Kg filed Critical Awd Pharma Gmbh & Co Kg
Application granted granted Critical
Publication of DK0999828T3 publication Critical patent/DK0999828T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK98943632T 1997-07-10 1998-07-01 Fremgangsmåde til fremstilling af præparater med aktivt middel til kontrolleret frigivelse fra en matrix DK0999828T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19729487A DE19729487A1 (de) 1997-07-10 1997-07-10 Verfahren zur Herstellung von Wirkstoff-Zubereitungen mit kontrollierter Freisetzung aus einer Matrix
PCT/DE1998/001811 WO1999002134A2 (de) 1997-07-10 1998-07-01 Verfahren zur herstellung von wirkstoff-zubereitungen mit kontrollierter freisetzung aus einer matrix

Publications (1)

Publication Number Publication Date
DK0999828T3 true DK0999828T3 (da) 2004-01-19

Family

ID=7835229

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98943632T DK0999828T3 (da) 1997-07-10 1998-07-01 Fremgangsmåde til fremstilling af præparater med aktivt middel til kontrolleret frigivelse fra en matrix

Country Status (11)

Country Link
US (1) US6103264A (da)
EP (1) EP0999828B1 (da)
JP (1) JP2002511095A (da)
AT (1) ATE250410T1 (da)
AU (1) AU9151398A (da)
CA (1) CA2242552C (da)
DE (2) DE19729487A1 (da)
DK (1) DK0999828T3 (da)
ES (1) ES2207856T3 (da)
PT (1) PT999828E (da)
WO (1) WO1999002134A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1312058B1 (it) * 1999-04-09 2002-04-04 Pharmaplus S R L Metodo per la microincapsulazione di medicamenti.
DE10029201A1 (de) 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
ES2600577T3 (es) * 2003-12-04 2017-02-09 Bend Research, Inc. Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
KR20080064209A (ko) * 2003-12-04 2008-07-08 화이자 프로덕츠 인코포레이티드 바람직하게는 폴록사머와 글리세라이드를 함유하는다미립자 아지트로마이신 조성물의 제조를 위해 압출기를사용하는 분무응결 방법
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
JP2007513146A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 液体系プロセスによるアジスロマイシンマルチパーティキュレート剤形
KR100844628B1 (ko) * 2003-12-04 2008-07-07 화이자 프로덕츠 인크. 제약상 다입자의 제조 방법
JP2007513139A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 安定性の改善した多粒子組成物
US20060204613A1 (en) * 2005-02-18 2006-09-14 Castro Armando J Chewing gum containing flavor delivery systems
US20060286200A1 (en) * 2005-04-18 2006-12-21 Castro Armando J Confections containing flavor delivery systems
CA2605792A1 (en) * 2005-04-25 2006-11-02 Teva Pharmaceuticals Usa, Inc. Extended release formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3080293A (en) * 1960-08-02 1963-03-05 Hoffmann La Roche Process of making pleasant-tasting niacinamide beadlets
DE1617593A1 (de) * 1965-10-12 1971-04-29 Leo Pharm Prod Ltd Verfahren zur Herstellung von Tabletten oder Pillen
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
WO1993007859A1 (en) * 1991-10-23 1993-04-29 Warner-Lambert Company Novel pharmaceutical pellets and process for their production
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
PT654263E (pt) * 1993-11-23 2002-06-28 Euro Celtique Sa Metodo para a preparacao de uma composicao de libertyacao prolongada
EP0672416A1 (en) * 1994-03-14 1995-09-20 Euro-Celtique S.A. Pharmaceutical composition comprising diamorphine

Also Published As

Publication number Publication date
CA2242552C (en) 2002-02-05
AU9151398A (en) 1999-02-08
CA2242552A1 (en) 1999-01-10
JP2002511095A (ja) 2002-04-09
ES2207856T3 (es) 2004-06-01
PT999828E (pt) 2004-02-27
DE19729487A1 (de) 1999-01-14
US6103264A (en) 2000-08-15
WO1999002134A3 (de) 1999-05-14
ATE250410T1 (de) 2003-10-15
EP0999828B1 (de) 2003-09-24
DE59809737D1 (de) 2003-10-30
EP0999828A2 (de) 2000-05-17
WO1999002134A2 (de) 1999-01-21

Similar Documents

Publication Publication Date Title
DK0999828T3 (da) Fremgangsmåde til fremstilling af præparater med aktivt middel til kontrolleret frigivelse fra en matrix
DK0641195T3 (da) Fremgangsmåde til fremstilling af lægemiddelblandinger med forsinket virkning
DK0455391T3 (da) Granulerede præparater og fremgangsmåde til fremstilling heraf
UA26449C2 (uk) Тверда лікарська форма для оральhого застосуваhhя з сповільhеhим вивільhеhhям активhої речовиhи і спосіб її виготовлеhhя (варіаhти)
CA2335179A1 (en) Tablet and process for making the same
NO893893D0 (no) Granulaere farmasoeytiske formuleringer.
HUT49113A (en) Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components
WO2001041733A3 (en) Compressed tablet composition comprising a nsaid
ID27474A (id) Proses pembuatan senyawa pupuk bentuk granul
WO2002098391A3 (en) Process for preparing granular compositions
DK0762865T3 (da) Fremgangsmåde til fremstilling af perler indeholdende et aktivt stof med ubestemt smeltepunkt og de herved opnåede perler
ATE374027T1 (de) Eine kondensierte indolverbindung enthaltendes arzneimittel
AU4398000A (en) A process for the microencapsulation of medicaments
IT8819211A0 (it) Procedimento di fabbricazione di perborato di sodio monoidrato, perborato di sodio monoidrato parzialmente cristallizzato e polveri per lisciviare materiali tessili.
TH45381A (th) 1,2,4-ไทรอะโซโล [3,4-a] ไพริดาซีนที่ถูกแทนที่
UA30026A (uk) Спосіб очистки від домішок та вирощування монокристалів тугоплавких матеріалів